Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study

Severe COVID-19 patients demonstrate hypercoagulability, necessitating thromboprophylaxis. However, less is known about the haemostatic profile in mild COVID-19 patients. We performed an age and gender-matched prospective study of 10 severe and 10 mild COVID-19 patients. Comprehensive coagulation pr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2022-04, Vol.53 (3), p.646-662
Hauptverfasser:	Fan, Bingwen Eugene, Ramanathan, Kollengode, Sum, Christina Lai Lin, Christopher, Dheepa, Chan, Stephrene Seok Wei, Lim, Gek Hsiang, Bok, Chwee Fang, Wong, Shiun Woei, Lye, David Chien, Young, Barnaby Edward, Lim, Jia Yan, Lee, Rui Min, Lim, Shu Ping, Tan, Hwee Tat, Ang, Mui Kia, Lau, Soon Lee, Kuperan, Ponnudurai, Ong, Kiat Hoe, Chia, Yew Woon
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use Cardiology Coagulation factors Coronaviruses COVID-19 COVID-19 - complications Factor VIII Fibrinogen Fibrinogen - analysis Hematology Hemostatics Humans Hypoxia Medicine Medicine & Public Health Prospective Studies Thrombelastography Thromboembolism Thrombophilia - diagnosis Thrombophilia - etiology Thrombosis - drug therapy Venous Thromboembolism - drug therapy Von Willebrand factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!